Verdict91/ 100
Ranked #2 · Grade A−Partner
Eden review
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit Eden Partner — we may earn a commission, at no cost to you. It never changes the score.
- Semaglutide
- $239/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
Eden scored on our six published factors. See the methodology.
Real-world results90/100
Price honesty89/100
Prescriber access95/100
Formulary choice86/100
Cancellation fairness90/100
Member support92/100
What we like
- High verification confidence — clear supply-chain and clinician disclosure
- Nationwide availability
- Both molecules offered
The caveats
- Premium pricing vs the cheapest tiers
- Compounded only — no brand-name access
The verdict
Best for: People who prioritize a vetted, high-transparency provider over the lowest sticker price. A polished, high-disclosure compounded program with strong nationwide coverage.
Pricing, states and verification reflect Eden's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Eden's site. Not medical advice; see our disclosure.